🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
The investigators propose this study utilizing Lenalidomide, Adriamycin, De...
Status
Unknown
Location
Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie
Start Date
2012-05
Trial ID
NCT01685814
Treatments Being Tested
The purpose of this study is to determine whether the combination of bevaci...
Status
Terminated
Location
The Cancer Center at Hackensack University Medical Center
Start Date
2007-04
Trial ID
NCT00464178
Treatments Being Tested
This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
Status
Completed
Location
Northwestern Medical Faculty Foundation
Start Date
2008-01
Trial ID
NCT00555906
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
The purpose of this study is to determine whether the combination of bendam...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00426855
Treatments Being Tested
The goal of this study is to evaluate the safety of melphalan and autologou...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2005-05
Trial ID
NCT00793650
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
Objectives The primary objective of this study is to: • determine the com...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2007-05
Trial ID
NCT00504751
Treatments Being Tested
An unrandomized phase 2 study of selinexor in combination with lenalidomide...
Status
Active Not Recruiting
Location
Aalborg University Hospital
Start Date
2021-08-18
Trial ID
NCT04717700
Treatments Being Tested